Aron Shapiro

Responsible for Ora’s investment, strategic partnering and risk sharing/sweat equity activities. Represent Ora’s GP and LP collaboration with InFocus Capital Partners, a venture capital firm specialized in ophthalmic innovation investments. Support deal flow, diligence and investment thesis analyses for InFocus.

Serving as Chief Commercial Officer, responsible for global business development and sales activities. Serving as Sr. VP and Therapeutic Area Head, led and managed clinical-regulatory strategy for international ophthalmic development programs, including clinical development plan designs and full clinical protocols for retina, glaucoma, infection, inflammation, refractive disorders and device therapeutic areas. Represented clients at regulatory meetings. Successfully negotiated many ophthalmic pivotal study endpoints and trials design with FDA, EMA and other international regulatory agencies. Led Ora’s global geographic expansion strategy for clinical and regulatory operations in Europe. Established and built relationships with leading international ophthalmology KOLs. Led strategy, development and commercialization of Ora’s Visual Navigation Challenge (Ora VNC), a standardized mobility test used as a primary endpoint for inherited retinal disease clinical trials, and Ora's Best Corrected Visual Acuity endpoint training and certification business unit.